Product Description
Fasenra Pen Injection consists of the active ingredient Benralizumab. It is indicated as an add-on maintenance therapy for eosinophilic asthma in patients older than 12 years of age. Asthma is a chronic airway disorder where inflammation limits airflow through the lungs, resulting in symptoms of breathlessness, wheezing and chest tightness. Eosinophilic asthma is a condition where the cause of asthma is the abnormal levels of eosinophils in the blood or lungs.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Uses
Treatment of Asthma/COPD
Side Effects
- Headache
- Sore throat
- Rashes
- Fever
- Injection site reactions
- Muscle pain
Storage
Do not freeze,Store in a refrigerator 2 - 8℃
0.0
0 Reviews